Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Thelin sitaxsentan cardiovascular data

A retrospective chart review of 14 ES patients who took 100

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE